Patients with artificial heart valves face thrombo-embolic risks. A new risk score helps tailor antiplatelet therapy, reducing unnecessary anticoagulation and improving patient outcomes.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: